A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

November 28, 2020

Study Completion Date

November 28, 2020

Conditions

Unresectable Locally Advanced Pancreatic Carcinoma

Interventions

DEVICE

OncoSil™

The implantation of OncoSil™ under EUS

Trial Locations (4)

Johns Hopkins Hospital, Baltimore

Moffitt Cancer Centre, Tampa

MD Anderson Cancer Center, Houston

Cedars Sinai Department of Radiation Oncology, Los Angeles